These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 5309490)

  • 1. The role of antineuraminidase antibody in immunity to influenza virus infection.
    Schulman JL
    Bull World Health Organ; 1969; 41(3):647-50. PubMed ID: 5309490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunity to influenza.
    Schild GC; Oxford JS; Virelizier JL
    Dev Biol Stand; 1975; 28():253-72. PubMed ID: 47824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of antineuraminidase antibodies in protection against influenza].
    Aymard M; Gerentes L; Kessler N
    Bull Acad Natl Med; 1998; 182(8):1723-36; discussion 1736-7. PubMed ID: 10188318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.
    Sandbulte MR; Jimenez GS; Boon AC; Smith LR; Treanor JJ; Webby RJ
    PLoS Med; 2007 Feb; 4(2):e59. PubMed ID: 17298168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterotypic protective immune reactions in mice infected with distinct serotypes of human influenza virus.
    Floc'h F; Werner GH
    Ann Microbiol (Paris); 1978; 129(4):509-24. PubMed ID: 308787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antigenic relationship of the neuraminidase of Hong Kong virus to that of other human strains of influenza A virus.
    Schulman JL; Kilbourne ED
    Bull World Health Organ; 1969; 41(3):425-8. PubMed ID: 5309451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of neuraminidase on potency of inactivated influenza virus vaccines in mice.
    Reichert E; Mauler R
    Dev Biol Stand; 1975; 28():319-23. PubMed ID: 1126575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purified viral neuraminidase vaccine to control influenza.
    Arora DJ
    Can Med Assoc J; 1979 Dec; 121(12):1575-9. PubMed ID: 394829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental infection of human volunteers with a swine influenzavirus antigenically related to the human A-Hong Kong-68 virus.
    Beare AS; Schild GC; Hall TS
    Bull World Health Organ; 1972; 47(4):493-5. PubMed ID: 4541000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The origin of pandemic influenza.
    Webster RG; Laver WG
    Bull World Health Organ; 1972; 47(4):449-52. PubMed ID: 4540994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
    Tamura S; Kurata T
    Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of immunity in influenza].
    Zilişteanu E; Creţescu L; Maţepiuc
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1975; 20(3):137-46. PubMed ID: 128102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the antigenicity of influenza virus aluminum oxide adjuvant vaccine "Alorbat" in man (author's transl)].
    Desselberger U; Pressler K; Erdmann G
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):160-77. PubMed ID: 1179878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus.
    Schild GC; Oxford JS; Dowdle WR; Coleman M; Pereira MS; Chakraverty P
    Bull World Health Organ; 1974; 51(1):1-11. PubMed ID: 4218138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineuraminidase antibody response of man to influenza virus neuraminidase N2: results obtained with an improved hemagglutination inhibition technique and an enzyme inhibition test.
    Hennessy AV; Minuse E; Davenport FM
    J Immunol; 1972 Aug; 109(2):213-6. PubMed ID: 5047368
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of immunity on transmission of influenza: experimental studies.
    Schulman JL
    Prog Med Virol; 1970; 12():128-60. PubMed ID: 4921481
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental infection in man and horses with influenza A viruses.
    Kasel JA; Couch RB
    Bull World Health Organ; 1969; 41(3):447-52. PubMed ID: 5309454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.